Biosimilars Explainer
A biosimilar is a biologic medicine that is highly similar to an already approved biologic, called the reference product, with no clinically meaningful differences in safety, purity, or potency. Biologics are large, complex products made using living systems, so exact molecular copies are generally not possible.
Regulators evaluate the totality of evidence, including detailed analytical comparisons, manufacturing controls, biological activity, pharmacology, immunogenicity, and clinical data as needed. The aim is to resolve uncertainty about meaningful differences rather than repeat every study performed for the reference product.
Biosimilars are not the same as conventional generics. Small-molecule generic active ingredients can usually be reproduced more exactly, while biologics naturally show small variation within and between batches. Both reference biologics and biosimilars must maintain tight quality standards.
An interchangeable biosimilar meets additional legal requirements that may permit pharmacy-level substitution, subject to state law. A biosimilar without that designation can still be prescribed and is FDA-approved as safe and effective for its approved uses. Patients should discuss product names, insurance coverage, administration, and monitoring with the care team.
Developers compare structure, function, purity, potency, pharmacology, immune response, and clinical performance with the reference product.
Minor differences are acceptable only when they do not create clinically meaningful differences in safety or effectiveness.
Biologics are produced in living systems and are much larger and more complex than most chemically synthesized drugs.
The regulatory pathway therefore emphasizes extensive analytical similarity rather than proof of an identical molecule.
Interchangeable is a U.S. regulatory designation related to substitution. It is not a higher level of clinical quality than an approved biosimilar.
Whether a pharmacy can substitute depends on the designation and state law. Prescribers can prescribe approved biosimilars directly.
Explore more "Explainers"
Discover additional explainers across politics, science, business, technology, and other fields. Each explainer breaks down a complex idea into clear, everyday language—helping you better understand how major concepts, systems, and debates shape the world around us.
